Search
forResearch 10 of 1000+
- OCT4 maintains self-renewal and reverses senescence in human hair follicle mesenchymal stem cells through the downregulation of p21 by DNA methyltransferases
- Transdifferentiation of Human Hair Follicle Mesenchymal Stem Cells into Red Blood Cells by OCT4
- Role of OCT4 in the Regulation of FSH-Induced Granulosa Cells Growth in Female Mice
- ZO-1 boosts the in vitro self-renewal of pre-haematopoietic stem cells from OCT4-reprogrammed human hair follicle mesenchymal stem cells through cytoskeleton remodeling
- 41551 Feasibility of using an integrated RCM-OCT device to identify thin Basal Cell Carcinomas amenable to ablative therapy with a Er:YAG laser: A Prospective Observational Study
- Dauricine attenuates Oct4/sonic hedgehog co‐activated stemness and induces reactive oxygen species‐mediated mitochondrial apoptosis via AKT/β‐catenin signaling in human neuroblastoma and glioblastoma stem‐like cells
- International Conference on Skin Therapy and Cosmetics Cannes, France, Sept. 29-Oct. 4, 1985
- Glycyrrhizic acid attenuates stem cell-like phenotypes of human dermal papilla cells
- Immunologic findings in central centrifugal cicatricial alopecia
- The effect of glycyrrhizic acid and aqueous licorice extract on hair growth retardation : in vitro mechanistic and efficacy studies in human
Community 7 of 10
- [32M] 4 months into 5mg fin and oral min. (Oct. ‘25 vs. Jan ‘26)
- OCT 2023 - JAN 2025 progress results
- Hair Regrowth timeline (Oct. 2024 - Till now)
- Progress post: Oct 2023-current. 1mg oral fin, topical min, seldom dermastamp
- Topical Min Progress Oct 2024 - Feb 2025
- 16 months progress pictures (Oct 2023 - Jan 2025)
- What new hair-loss treatments actually look exciting right now (Oct 2025)
Learn
— no results
Try a deeper search in learn →